FASN-IN-4

Category	SARS-CoV
CAS	1375105-96-6
Description	FAS-IN-1, a diazaspiro derivative, has been found to be a fatty acid synthase inhibitor that probably have potential biological usage in anticancer study.

Quotation Now

Synonyms	FAS-IN-1;1375105-96-6;FASN-IN-4;CHEMBL2147032;4-cyclopropyl-9-(4-quinolin-7-ylphenyl)sulfonyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SCHEMBL4541971;OGGOWHOQMIINAZ-UHFFFAOYSA-N;BCP28627;BDBM50391837;AKOS030526462;CS-3932;4-Cyclopropyl-9-((4-(quinolin-7-yl)phenyl)sulfonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;NCGC00485940-01;DA-63380;HY-12648;A906146;4-cyclopropyl-9-{[4-(7-quinolinyl)phenyl]sulfonyl}-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;
IUPAC Name	4-cyclopropyl-9-(4-quinolin-7-ylphenyl)sulfonyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
Molecular Weight	477.58
Molecular Formula	C26H27N3O4S
Canonical SMILES	O=C1COC2(CCN(S(=O)(C3=CC=C(C4=CC=C5C=CC=NC5=C4)C=C3)=O)CC2)CN1C6CC6
InChI	InChI=1S/C26H27N3O4S/c30-25-17-33-26(18-29(25)22-7-8-22)11-14-28(15-12-26)34(31,32)23-9-5-19(6-10-23)21-4-3-20-2-1-13-27-24(20)16-21/h1-6,9-10,13,16,22H,7-8,11-12,14-15,17-18H2
InChIKey	OGGOWHOQMIINAZ-UHFFFAOYSA-N
Purity	98%
Solubility	10 mM in DMSO
Appearance	Solid
Application	FAS-IN-1 has been found to be a fatty acid synthase inhibitor that probably have potential biological usage in anticancer study.
Shelf Life	As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Storage	-20°C Freeze